References
1.Kalia LV, Lang AE (2015) Parkinson’s disease. Lancet 386:896–912
2.Conway KA et al (2000) Acceleration of oligomerization, not fibrillization, is a shared property of both α-synuclein mutations linked to early-onset Parkinson’s disease: Implications for pathogenesis and therapy. Proceedings of the National Academy of Sciences 97, 571–576
3.Flagmeier P et al (2016) Mutations associated with familial Parkinson’s disease alter the initiation and amplification steps of α-synuclein aggregation. Proceedings of the National Academy of Sciences 113, 10328–10333
4.Meade RM, Fairlie DP, Mason JM (2019) Alpha-synuclein structure and Parkinson’s disease – lessons and emerging principles. Mol Neurodegeneration 14:29
5.Winner B et al (2011) In vivo demonstration that α-synuclein oligomers are toxic. Proceedings of the National Academy of Sciences 108, 4194–4199
6.Eliezer D, Kutluay E, Bussell R, Browne G (2001) Conformational properties of α-synuclein in its free and lipid-associated states1. J Mol Biol 307:1061–1073
7.Jao CC, Hegde BG, Chen J, Haworth IS, Langen R (2008) Structure of membrane-bound α-synuclein from site-directed spin labeling and computational refinement. Proceedings of the National Academy of Sciences 105, 19666–19671
8.Weinreb PH, Zhen W, Poon AW, Conway KA, Lansbury PT, NACP (1996) A Protein Implicated in Alzheimer’s Disease and Learning, Is Natively Unfolded. Biochemistry 35:13709–13715
9.Mahul-Mellier A-L et al (2025) Differential role of C-terminal truncations on alpha-synuclein pathology and Lewy body formation. npj Parkinsons Dis 11:261
10.Zarranz JJ et al (2004) The new mutation, E46K, of α-synuclein causes parkinson and Lewy body dementia. Ann Neurol 55:164–173
11.Greenbaum EA et al (2005) The E46K Mutation in α-Synuclein Increases Amyloid Fibril Formation*. J Biol Chem 280:7800–7807
12.Machiya Y et al (2010) Phosphorylated α-Synuclein at Ser-129 Is Targeted to the Proteasome Pathway in a Ubiquitin-independent Manner*. J Biol Chem 285:40732–40744
13.Ma L et al (2018) C-terminal truncation exacerbates the aggregation and cytotoxicity of α-Synuclein: A vicious cycle in Parkinson’s disease. Biochim et Biophys Acta (BBA) - Mol Basis Disease 1864:3714–3725
14.Sorrentino ZA et al (2018) Physiological C-terminal truncation of α-synuclein potentiates the prion-like formation of pathological inclusions. J Biol Chem 293:18914–18932
15.Murray IVJ et al (2003) Role of α-Synuclein Carboxy-Terminus on Fibril Formation in Vitro. Biochemistry 42:8530–8540
16.Liu C-W et al (2005) A Precipitating Role for Truncated α-Synuclein and the Proteasome in α-Synuclein Aggregation: IMPLICATIONS FOR PATHOGENESIS OF PARKINSON DISEASE*. J Biol Chem 280:22670–22678
17.Thrush RJ, Vadukul DM, Aprile FA (2022) A Facile Method to Produce N-Terminally Truncated α-Synuclein. Front Neurosci 16
18.Thrush RJ, Vadukul DM, Allerton SC, Storch M, Aprile FA (2024) Surface Wetting Is a Key Determinant of α-Synuclein Condensate Maturation. 06.06.597302 Preprint at https://doi.org/10.1101/2024.06.06.597302 (2025)
19.Vamvaca K, Volles MJ, Lansbury PT (2009) The First N-terminal Amino Acids of α-Synuclein Are Essential for α-Helical Structure Formation In Vitro and Membrane Binding in Yeast. J Mol Biol 389:413–424
20.Santos J et al (2024) A Targetable N-Terminal Motif Orchestrates α-Synuclein Oligomer-to-Fibril Conversion. J Am Chem Soc 146:12702–12711
21.Lööv C, Scherzer CR, Hyman BT, Breakefield XO, Ingelsson M (2016) α-Synuclein in Extracellular Vesicles: Functional Implications and Diagnostic Opportunities. Cell Mol Neurobiol 36:437–448
22.Lee H-J, Bae E-J, Lee S-J (2014) Extracellular α-synuclein—a novel and crucial factor in Lewy body diseases. Nat Rev Neurol 10:92–98
23.Klegeris A et al (2006) Alpha-synuclein and its disease-causing mutants induce ICAM-1 and IL-6 in human astrocytes and astrocytoma cells. FASEB J 20:2000–2008
24.Lee H-J et al (2010) Direct Transfer of α-Synuclein from Neuron to Astroglia Causes Inflammatory Responses in Synucleinopathies*. J Biol Chem 285:9262–9272
25.Roodveldt C, Christodoulou J, Dobson CM (2008) Immunological features of α-synuclein in Parkinson’s disease. J Cell Mol Med 12:1820–1829
26.Davie EW, Kulman JD (2006) An Overview of the Structure and Function of Thrombin. Semin Thromb Hemost 32:3–15
27.Di Cera E, Thrombin (2008) Mol Aspects Med 29:203–254
28.Arai T, Miklossy J, Klegeris A, Guo J-P, McGeer PL (2006) Thrombin and Prothrombin Are Expressed by Neurons and Glial Cells and Accumulate in Neurofibrillary Tangles in Alzheimer Disease Brain. J Neuropathol Exp Neurol 65:19–25
29.Krenzlin H, Lorenz V, Danckwardt S, Kempski O, Alessandri B (2016) The Importance of Thrombin in Cerebral Injury and Disease. Int J Mol Sci 17:84
30.Shlobin NA, Har-Even M, Itsekson-Hayosh Z, Harnof S, Pick CG (2021) Role of Thrombin in Central Nervous System Injury and Disease. Biomolecules 11:562
31.Rajput PS et al (2020) Neuron-generated thrombin induces a protective astrocyte response via protease activated receptors. Glia 68:246–262
32.Chen X et al (2022) Thrombin induces morphological and inflammatory astrocytic responses via activation of PAR1 receptor. Cell Death Discov 8:189
33.Ye F, Garton HJL, Hua Y, Keep RF, Xi G (2021) The Role of Thrombin in Brain Injury After Hemorrhagic and Ischemic Stroke. Transl Stroke Res 12:496–511
34.Turgeon VL, Houenou LJ (1997) The role of thrombin-like (serine) proteases in the development, plasticity and pathology of the nervous system. Brain Res Rev 25:85–95
35.Vaughan PJ, Su J, Cotman CW, Cunningham DD (1994) Protease nexin-1, a potent thrombin inhibitor, is reduced around cerebral blood vessels in Alzheimer’s disease. Brain Res 668:160–170
36.Johnson SL, Iannucci J, Seeram NP, Grammas P (2020) Inhibiting thrombin improves motor function and decreases oxidative stress in the LRRK2 transgenic Drosophila melanogaster model of Parkinson’s disease. Biochem Biophys Res Commun 527:532–538
37.Ramis R, Ortega-Castro J, Vilanova B, Adrover M, Frau J (2020) Unraveling the NaCl Concentration Effect on the First Stages of α-Synuclein Aggregation. Biomacromolecules 21:5200–5212
38.Pelc LA, Koester SK, Kukla CR, Chen Z, Di Cera E (2022) The active site region plays a critical role in Na + binding to thrombin. J Biol Chem 298:101458
39.Ayala Y, Cera ED (1994) Molecular Recognition by Thrombin. Role of the Slows→Fast Transition, Site-specific Ion Binding Energetics and Thermodynamic Mapping of Structural Components. J Mol Biol 235:733–746
40.Egidi I, Guidi M, Giove F (2025) Compartmentalization of sodium in the human brain: a mini-review of 23Na-MRI methods. Front Phys 13
41.Dang OD, Vindigni A, Di Cera E (1995) An allosteric switch controls the procoagulant and anticoagulant activities of thrombin. Proceedings of the National Academy of Sciences 92, 5977–5981
42.Stojanovski BM, Pelc LA, Di Cera E (2024) Thrombin has dual trypsin-like and chymotrypsin-like specificity. J Thromb Haemost 22:1009–1015
43.Hubbard SJ (1998) The structural aspects of limited proteolysis of native proteins. Biochim et Biophys Acta (BBA) - Protein Struct Mol Enzymol 1382:191–206
44.Borthakur K, Sisk TR, Panei FP, Bonomi M, Robustelli P (2025) Determining accurate conformational ensembles of intrinsically disordered proteins at atomic resolution. Nat Commun 16:9036
45.Fongaro B, Cappelletto E, Sosic A, Spolaore B (2022) Polverino de Laureto, P. 3,4-Dihydroxyphenylethanol and 3,4-dihydroxyphenylacetic acid affect the aggregation process of E46K variant of α-synuclein at different extent: Insights into the interplay between protein dynamics and catechol effect. Protein Sci 31:e4356
46.van Heuvel RH den, Heck AJ (2004) Native protein mass spectrometry: from intact oligomers to functional machineries. Current Opinion in Chemical Biology 8, 519–526
47.Davidson WS, Jonas A, Clayton DF, George JM (1998) Stabilization of α-Synuclein Secondary Structure upon Binding to Synthetic Membranes*. J Biol Chem 273:9443–9449
48.Fusco G et al (2014) Direct observation of the three regions in α-synuclein that determine its membrane-bound behaviour. Nat Commun 5:3827
49.Rizzotto E et al (2025) DOPAC as a modulator of α-Synuclein and E46K interactions with membrane: Insights into binding dynamics. Int J Biol Macromol 294:139427
50.Choi S-H, Lee DY, Kim SU, Jin BK (2005) Thrombin-Induced Oxidative Stress Contributes to the Death of Hippocampal Neurons In Vivo: Role of Microglial NADPH Oxidase. J Neurosci 25:4082–4090
51.Gallwitz M, Enoksson M, Thorpe M, Hellman L (2012) The Extended Cleavage Specificity of Human Thrombin. PLoS ONE 7:e31756
52.Uliana F et al (2021) Mapping specificity, cleavage entropy, allosteric changes and substrates of blood proteases in a high-throughput screen. Nat Commun 12:1693
53.Kim KS et al (2012) Proteolytic Cleavage of Extracellular α-Synuclein by Plasmin: IMPLICATIONS FOR PARKINSON DISEASE*. J Biol Chem 287:24862–24872
54.Leem E, Jeong KH, Won S-Y, Shin W-H, Kim SR (2016) Prothrombin Kringle-2: A Potential Inflammatory Pathogen in the Parkinsonian Dopaminergic System. Experimental Neurobiol 25:147–155
55.Ben Shimon M et al (2015) Thrombin regulation of synaptic transmission and plasticity: implications for health and disease. Front Cell Neurosci 9
56.Fusco G et al (2016) Structural Ensembles of Membrane-bound α-Synuclein Reveal the Molecular Determinants of Synaptic Vesicle Affinity. Sci Rep 6:27125
57.Cholak E et al (2020) Avidity within the N-terminal anchor drives α-synuclein membrane interaction and insertion. FASEB J 34:7462–7482
58.Khounlo R et al (2021) Membrane Binding of α-Synuclein Stimulates Expansion of SNARE-Dependent Fusion Pore. Front Cell Dev Biol 9
59.Maltsev AS, Chen J, Levine RL, Bax A (2013) Site-Specific Interaction between α-Synuclein and Membranes Probed by NMR-Observed Methionine Oxidation Rates. J Am Chem Soc 135:2943–2946
60.McGlinchey RP, Ni X, Shadish JA, Jiang J, Lee JC (2021) The N terminus of α-synuclein dictates fibril formation. Proceedings of the National Academy of Sciences 118, e2023487118
61.Dewison KM et al (2024) Residues 2 to 7 of α-synuclein regulate amyloid formation via lipid-dependent and lipid-independent pathways. Proceedings of the National Academy of Sciences 121, e2315006121
62.Gill SC, von Hippel PH (1989) Calculation of protein extinction coefficients from amino acid sequence data. Anal Biochem 182:319–326
63.Rovere M (1948) Circular Dichroism and Isothermal Titration Calorimetry to Study the Interaction of α-Synuclein with Membranes. Methods Mol Biol 123–143 (2019)
A
64.Wei Y, Thyparambil AA, Latour RA (2014) Protein helical structure determination using CD spectroscopy for solutions with strong background absorbance from 190 to 230 nm. Biochim et Biophys Acta (BBA) - Proteins Proteom 1844:2331–2337
65.Peterle D, Wales TE, Engen JR (2022) Simple and Fast Maximally Deuterated Control (maxD) Preparation for Hydrogen–Deuterium Exchange Mass Spectrometry Experiments. Anal Chem 94:10142–10150
66.Meisl G et al (2016) Molecular mechanisms of protein aggregation from global fitting of kinetic models. Nat Protoc 11:252–272